Skip to main content

Activist VenBio Wins Control of Immunomedics Board

VenBio gained four seats on Immunomedics' board of directors.

Following a shareholder vote, activist VenBio Select Advisor won a contentious proxy fight against Immunomedics (IMMU) - Get Immunomedics, Inc. Report , of which it is the largest shareholder. VenBio gained 4 seats on the drug-maker's board of directors. 

READ THE FULL STORY HERE: Activist Investor Wins Control of Immunomedics Board Following Shareholder Vote

This article was written by

TheStreet Recommends

a staff member of TheStreet